Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Metallothionein 2A
Introduction
Metallothionein-2 is a protein that in humans is encoded by the MT2A gene.[1][2]
References
References
- ↑ Karin M, Richards RI (Dec 1982). “Human metallothionein genes–primary structure of the metallothionein-II gene and a related processed gene”. Nature. 299 (5886): 797–802. Bibcode:1982Natur.299..797K. doi:10.1038/299797a0. PMID 7133118.
- ↑ “Entrez Gene: MT2A metallothionein 2A”.
- ↑ Rao, Prema S; Jaggi Meena; Smith David J; Hemstreet George P; Balaji K C (Oct 2003). “Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer”. Biochem. Biophys. Res. Commun. United States. 310 (3): 1032–8. doi:10.1016/j.bbrc.2003.09.118. ISSN 0006-291X. PMID 14550308.
Further reading
Further reading
- Kissling MM, Kägi HR (1977). “Primary structure of human hepatic metallothionein”. FEBS Lett. 82 (2): 247–50. doi:10.1016/0014-5793(77)80594-2. PMID 913597.
- Yamazaki S, Nakanishi M, Hamamoto T, et al. (1993). “Expression of human metallothionein-II fusion protein in Escherichia coli”. Biochem. Int. 28 (3): 451–60. PMID 1339282.
- Messerle BA, Schäffer A, Vasák M, et al. (1992). “Comparison of the solution conformations of human [Zn7]-metallothionein-2 and [Cd7]-metallothionein-2 using nuclear magnetic resonance spectroscopy”. J. Mol. Biol. 225 (2): 433–43. doi:10.1016/0022-2836(92)90930-I. PMID 1593628.
- Zafarullah M, Martel-Pelletier J, Cloutier JM, et al. (1992). “Expression of c-fos, c-jun, jun-B, metallothionein and metalloproteinase genes in human chondrocyte”. FEBS Lett. 306 (2–3): 169–72. doi:10.1016/0014-5793(92)80992-P. PMID 1633872.
- Messerle BA, Schäffer A, Vasák M, et al. (1990). “Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy”. J. Mol. Biol. 214 (3): 765–79. doi:10.1016/0022-2836(90)90291-S. PMID 2388267.
- Duguid JR, Bohmont CW, Liu NG, Tourtellotte WW (1989). “Changes in brain gene expression shared by scrapie and Alzheimer disease”. Proc. Natl. Acad. Sci. U.S.A. 86 (18): 7260–4. Bibcode:1989PNAS…86.7260D. doi:10.1073/pnas.86.18.7260. PMC 298037. PMID 2780570.
- Karin M, Haslinger A, Heguy A, et al. (1987). “Metal-responsive elements act as positive modulators of human metallothionein-IIA enhancer activity”. Mol. Cell. Biol. 7 (2): 606–13. PMC 365115. PMID 3821726.
- Karin M, Haslinger A, Holtgreve H, et al. (1984). “Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene”. Nature. 308 (5959): 513–9. Bibcode:1984Natur.308..513K. doi:10.1038/308513a0. PMID 6323998.
- Schmidt CJ, Hamer DH, McBride OW (1984). “Chromosomal location of human metallothionein genes: implications for Menkes’ disease”. Science. 224 (4653): 1104–6. Bibcode:1984Sci…224.1104S. doi:10.1126/science.6719135. PMID 6719135.
- Karin M, Richards RI (1982). “Human metallothionein genes: molecular cloning and sequence analysis of the mRNA”. Nucleic Acids Res. 10 (10): 3165–73. doi:10.1093/nar/10.10.3165. PMC 320698. PMID 6896577.
- Lambert E, Kille P, Swaminathan R (1996). “Cloning and sequencing a novel metallothionein I isoform expressed in human reticulocytes”. FEBS Lett. 389 (2): 210–2. doi:10.1016/0014-5793(96)00587-X. PMID 8766831.
- Woo ES, Dellapiazza D, Wang AS, Lazo JS (1999). “Energy-dependent nuclear binding dictates metallothionein localization”. J. Cell. Physiol. 182 (1): 69–76. doi:10.1002/(SICI)1097-4652(200001)182:1<69::AID-JCP8>3.0.CO;2-9. PMID 10567918.
- Jiang LJ, Vasák M, Vallee BL, Maret W (2000). “Zinc transfer potentials of the alpha – and beta-clusters of metallothionein are affected by domain interactions in the whole molecule”. Proc. Natl. Acad. Sci. U.S.A. 97 (6): 2503–8. Bibcode:2000PNAS…97.2503J. doi:10.1073/pnas.97.6.2503. PMC 15958. PMID 10716985.
- Garrett SH, Sens MA, Shukla D, et al. (2000). “Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer”. Prostate. 43 (2): 125–35. doi:10.1002/(SICI)1097-0045(20000501)43:2<125::AID-PROS7>3.0.CO;2-S. PMID 10754528.
- Ebert MP, Günther T, Hoffmann J, et al. (2000). “Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer”. Cancer Res. 60 (7): 1995–2001. PMID 10766190.
- Toyama M, Yamashita M, Hirayama N, Murooka Y (2003). “Interactions of arsenic with human metallothionein-2”. J. Biochem. 132 (2): 217–21. doi:10.1093/oxfordjournals.jbchem.a003213. PMID 12153718.
- Sun X, Kang YJ (2002). “Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity”. Exp. Biol. Med. (Maywood). 227 (8): 652–7. PMID 12192109.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Izmailova E, Bertley FM, Huang Q, et al. (2003). “HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages”. Nat. Med. 9 (2): 191–7. doi:10.1038/nm822. PMID 12539042.